Reaction Details |
| Report a problem with these data |
Target | G2/mitotic-specific cyclin-B1 |
---|
Ligand | BDBM43765 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Counterscreen assay for inhibitors of Wee1 degradation: dose response cell-based assay to identify inhibitors of cyclin B degradation |
---|
EC50 | >49750±n/a nM |
---|
Citation | PubChem, PC Counterscreen assay for inhibitors of Wee1 degradation: dose response cell-based assay to identify inhibitors of cyclin B degradation PubChem Bioassay(2008)[AID] |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
G2/mitotic-specific cyclin-B1 |
---|
Name: | G2/mitotic-specific cyclin-B1 |
Synonyms: | CCNB | CCNB1 | CCNB1_HUMAN |
Type: | Enzyme Subunit |
Mol. Mass.: | 48340.95 |
Organism: | Homo sapiens (Human) |
Description: | P14635 |
Residue: | 433 |
Sequence: | MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKM
PMKKEAKPSATGKVIDKKLPKPLEKVPMLVPVPVSEPVPEPEPEPEPEPVKEEKLSPEPI
LVDTASPSPMETSGCAPAEEDLCQAFSDVILAVNDVDAEDGADPNLCSEYVKDIYAYLRQ
LEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVP
KKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRP
LPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGE
WTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAKISTLPQLNS
ALVQDLAKAVAKV
|
|
|
BDBM43765 |
---|
n/a |
---|
Name | BDBM43765 |
Synonyms: | MLS000583103 | N-(2-furanylmethyl)-6-propyl-3-benzo[b][1,4]benzothiazepinecarboxamide | N-(2-furfuryl)-6-propyl-benzo[b][1,4]benzothiazepine-3-carboxamide | N-(2-furylmethyl)-11-propyldibenzo[b,f][1,4]thiazepine-8-carboxamide | N-(furan-2-ylmethyl)-6-propyl-benzo[b][1,4]benzothiazepine-3-carboxamide | N-(furan-2-ylmethyl)-6-propylbenzo[b][1,4]benzothiazepine-3-carboxamide | SMR000206289 | cid_12005219 |
Type | Small organic molecule |
Emp. Form. | C22H20N2O2S |
Mol. Mass. | 376.471 |
SMILES | CCCC1=Nc2cc(ccc2Sc2ccccc12)C(=O)NCc1ccco1 |t:3| |
Structure |
|